Doctor profile · Federal record
Dr. Oday Alhafidh, M.D
Pulmonary Disease Physician (CMS: Internal Medicine) · Internal Medicine Physician · Internal Medicine Physician · Sleep Medicine (Internal Medicine) Physician · Waxahachie, TX
- NPI 1619383429
- Accepts Medicare
- 29 yrs in practice
- Licensed in 2 states
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
141 Rvg Pkwy Ste 101
Waxahachie, TX 751655289
(972) 923-8923
fax (877) 399-8499 - Mailing address
-
4501 Southpointe Dr
Richardson, TX 750823890
Credentials & registration
- NPI registered
- July 2014 — 12 yrs on file
- Profile last updated
- May 24, 2024
- Year of graduation
- 1997 — 29 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State licenses (2)
- Texas #U1225 · New York #291156
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1619383429. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
284
Distinct HCPCS
4
Medicare allowed
$46,183
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99291 |
Critical care, first 30-74 minutes | 120 | 68 | $247 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 66 | 28 | $136 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 57 | 37 | $91 | |
99231 |
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 41 | 18 | $58 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 71. This provider delivers 4.0× the peer median.Open Payments
Industry payments received
All-time total
$1,632
Transactions
66
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $321.04 | |
| AstraZeneca Pharmaceuticals LP | 12 | $288.47 | |
| GlaxoSmithKline, LLC. | 17 | $250.63 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $208.31 | |
| Actelion Pharmaceuticals US, Inc. | 5 | $195.90 | |
| GENZYME CORPORATION | 3 | $95.52 | |
| Mallinckrodt Hospital Products Inc. | 3 | $75.50 | |
| Paratek Pharmaceuticals, Inc. | 2 | $47.37 | |
| Amgen Inc. | 2 | $34.29 | |
| United Therapeutics Corporation | 1 | $25.95 | |
| Electromed, Inc. | 1 | $24.49 | |
| Insmed, Inc. | 1 | $23.06 | |
| Grifols USA, LLC | 1 | $23.03 | |
| HARMONY BIOSCIENCES LLC | 1 | $18.68 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
381
Patients
280
Total drug cost
$94,685
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 84 | 63 | $2,018 |
| Prednisone | Generic | 52 | 45 | $177 |
| Fluticasone-Salmeterol (Fluticasone Propion/Salmeterol) | Brand | 35 | 25 | $5,635 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 34 | 22 | $27,996 |
| Incruse Ellipta (Umeclidinium Bromide) | Brand | 30 | 18 | $11,526 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 27 | 17 | $11,981 |
| Azithromycin | Generic | 21 | 21 | $124 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 21 | 17 | $16,483 |
| Montelukast Sodium | Generic | 19 | 16 | $176 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 17 | 13 | $11,485 |
Frequently asked questions
What is Dr. Oday Alhafidh's medical specialty?
Dr. Oday Alhafidh practices Pulmonary Disease Physician in Waxahachie, TX.
Where does Dr. Oday Alhafidh practice?
Dr. Oday Alhafidh practices at 141 Rvg Pkwy Ste 101, Waxahachie, TX 751655289. Office phone: 9729238923.
What is Dr. Oday Alhafidh's NPI?
Dr. Oday Alhafidh's National Provider Identifier (NPI) is 1619383429, issued by NPPES.
Does Dr. Oday Alhafidh accept Medicare assignment?
Yes. Dr. Oday Alhafidh accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Oday Alhafidh commonly perform?
Top Medicare-reported procedures in 2023: Critical care (HCPCS 99291); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232). Source: CMS Medicare Physician & Other Practitioners file.